Scientists investigate CD160 protein in corneal graft rejection
NCT ID NCT05009407
First seen Feb 23, 2026 · Last updated May 17, 2026 · Updated 7 times
Summary
This study looked at whether a protein called CD160 appears in new blood and lymph vessels in the cornea after a transplant. Researchers examined tissue from 43 adults who had corneal transplant surgery. The goal was to see if CD160 is linked to graft rejection, which could help find new ways to prevent it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANGIOGENESIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Damien JOLLY
Reims, France
Conditions
Explore the condition pages connected to this study.